Skip to Main Content

1,588

Views

2

CrossRef citations to date

0

Altmetric

Short Report

Immunogenicity and safety of a multi-dose quadrivalent inactivated influenza vaccine in individuals aged 6 months to 17 years: a randomized phase III trial

Joyce Ojedaa Global Clinical Science, Sanofi Pasteur, Mexico City, MexicoView further author information

,

José Luis Arredondob Instituto Nacional de Pediatría, Unidad de Investigación Clínica, Mexico City, MexicoView further author information

,

Perla Salcedoc Hospital General de Ecatepec “Las Américas”, Fraccionamiento las Américas, Ecatepec de Morelos, MexicoView further author information

,

Mercedes Paredes-Paredesd JM Research Clinical Research Center, Cuernavaca, MexicoView further author information

,

Martin Dupuye Global Biostatistical Sciences, Sanofi Pasteur, Marcy l’Étoile, FranceView further author information

,

Celine Petitf Global Clinical Immunology, Sanofi Pasteur, Marcy l’Étoile, FranceView further author information

,

Anne Laure Chabanong Global Pharmacovigilance, Sanofi Pasteur, Campus Sanofi Lyon, Lyon, FranceView further author information

,

Enrique Rivash Global Clinical Sciences, Sanofi Pasteur, Mexico City, MexicoView further author information

,

Sanjay Gurunathani Global Clinical Sciences, Sanofi Pasteur, Swiftwater, PA, USAView further author information

,

Iris De Bruijnj Global Clinical Sciences, Sanofi Pasteur, Marcy l’Étoile, FranceView further author information

&

Stephanie Pepinj Global Clinical Sciences, Sanofi Pasteur, Marcy l’Étoile, FranceCorrespondence[email protected]
View further author information